A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
Recruiting · NCT07606937 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma. | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Early phase 1 | 2026-06-05 | NCT07606937 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Shanghai Jiaotong University School of Medicine Ruijin Hospital | Shanghai | China | 3 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 2 |
| The Frist Affiliated Hospital of Soochow University | Suzhou | China | 1 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 20 |
| West China Hospotal Sichuan University | Chengdu | China | 1 |